Загрузка...
Quantifying the Benefits of Genome-Driven Oncology
The excitement surrounding genomically selected cancer therapy has led many to question whether this treatment paradigm is living up to its initial promise. The MOSCATO study suggests that a genome-driven strategy for cancer therapy improves outcomes in a significant minority of patients who undergo...
Сохранить в:
| Опубликовано в: : | Cancer Discov |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500977/ https://ncbi.nlm.nih.gov/pubmed/28576841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0380 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|